Drugs drug localization

Hyperosmolar drugs dehydrate local tissues, which causes irritation and increased peristalsis, with consequent evacuation of the fecal mass. Glycerin is a hyperosmolar drug. 

Juliano, R. L., and Me Cullough, H. N. (1980). Controlled delivery of an antitumor drug Localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system, J. Pharmacol. Exp. Ther., 214, 381-387. 

Kasprzyk-Hordem B, Dinsdale RM, Guwy AJ (2009) Illicit drugs and pharmaceuticals in the environment - forensic applications of environmental data. Part 1 Estimation of the usage of drugs in local communities. Environ Pollut 157 1773-1777... 

Transdermal and Topical Administration Transdermal administration is used to apply the drug on the skin surface. The drug is absorbed and transported by blood to receptors, which may be remote from the part of the skin where the transdermal patch is. The flrst pass metabohsm is circumvented. Topical administration is used to apply the drug for local effects. The typical areas for topical application are the skin, eyes, throat, nose, and vagina. 

Drugs are administered by various means from oral to intravenous to topical. The oral route is a relatively slow process where a drug must be absorbed across the GI tract and then passed through the liver and metabolized before it becomes available to bind to receptors and perform its intended function. On the other hand, intravenous application is quick but has the potential of fast systemic reaction if adverse reactions occur. In the case of topical administration, the effects of the drug are localized. 

Therefore, extensive characterization is required, as the physicochemical properties of lipid nanodispersions influence not only drug incorporation and release but also the physical stability of the preparation for example, drug localization in the matrix. Several methods have to be combined for characterization to allow detection of dynamic processes such as changes in lipid modifications, particle aggregation, and the formation of nanostructures of other kinds. 

Topically administered drugs with local action, and sustained-release drugs are special cases that require a specialised approach. 

Interaction with such properties does, however, not allow the investigator to answer the question of where the drug is localized in the particles (on the surface or in the crystal lattice). Thermal interactions were also observed when an incorporated drug or a second type of triglyceride formed a separate phase within the nanoparticles [3,37,64,68]. Drug release studies can provide supportive information on the accessibility of the drug to the aqueous phase [72,108], but separation of the effects from the nanoparticles from those of additional colloidal structures — if present — may be difficult. 

The clinician must report clinically important adverse drug effects to a committee or registry, which have responsibility for deciding on drug formularies (local or national) and for advice on therapeutics. 

Because of its anticholinergic properties, disopyramide should not be used in patients with glaucoma. Urinary retention and benign prostatic hypertrophy are also relative contraindications to disopyramide therapy. Patients with myasthenia gravis may have a myasthenic crisis after disopyramide administration as a result of the drug s local anesthetic action at the neuromuscular junction. The elderly patient may exhibit increased sensitivity to the anticholinergic actions of disopyramide. 

The rate of absorption of a local anesthetic into the bloodstream is affected by the dose administered, the vascularity at the site of injection, and the specific physicochemical properties of the drug itself. Local anesthetics gain entrance into the bloodstream by absorption from the injection site, direct intravenous injection, or absorption across the mucous membranes after topical application. Direct intravascular injection occurs accidentally when the needle used for infiltration of the local anesthetic lies within a blood vessel, or it occurs intentionally when Udocaine is used for the control of cardiac arrhythmias. 

The rectal route/vaginal route (drug administered locally to give a systanic effect),... 

The most frequent early complaints involve this organ system. Nausea, which typically occurs shortly after a dose, can be controlled by taking the drug with meals, and although sustained-release preparations can also help in this regard, they may lead to diarrhea because of the unabsorbed drug s local irritation to the bowel. 

A further property which is of central importance in diffusion is the tissue-binding capacity (or affinity) of a drug. Drugs that are highly lipid-soluble and protein-bound, such as bupivacaine and ropivacaine, are extensively bound to tissue. This limits the rate at which they are transferred from their intracellular sites of action to the vascular compartment. When tissue affinity is great the local anaesthetic effect is prolonged. 

Drugs with local anesthetic action block sodium channels and reduce the sodium current, INa. They are the oldest group of antiarrhythmic drugs and are still widely used. 

Marson AG et al Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy A systematic review. Epilepsy Res 2001 46 259. 

---